Rapport Therapeutics to Participate in Upcoming Investor Conferences Feb 24, 2026 04:05PM
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Sep 11, 2025 04:05PM
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Sep 11, 2025 04:05PM
Rapport prices public offering at $26 per share to raise $250 million Sep 9, 2025 09:17PM
Rapport Announces Pricing of Public Offering of Common Stock Sep 9, 2025 09:17PM


Sep 8, 2025 04:05PM Rapport Therapeutics announces $250 million public stock offering
Sep 8, 2025 04:05PM Rapport Announces Proposed Public Offering of Common Stock
Sep 8, 2025 09:20AM TD Cowen: 'Rapport Therapeutics (RAPP) Remains a Top Pick'
Jun 30, 2025 10:50AM TD Cowen on Rapport Therapeutics (RAPP): 'KOL at Investor Dinner Strongly Optimistic for RAP-219'
Feb 24, 2025 07:00AM Rapport Therapeutics to Participate in Upcoming Investor Conferences
Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Aug 29, 2024 07:00AM Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
Jul 2, 2024 05:30AM TD Cowen Starts Rapport Therapeutics (RAPP) at Buy
Jun 12, 2024 04:01PM Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
Jun 7, 2024 05:47AM Rapport Therapeutics (RAPP) Prices 8M Share IPO at $17/sh
Jun 6, 2024 06:54PM Rapport Therapeutics Announces Pricing of Initial Public Offering